About Kirin Holdings
Kirin Holdings is a company based in Nakano (Japan) founded in 2010. Kirin Holdings has completed 1 acquisition, including Blackmores. Kirin Holdings offers products and services including Kirin Brewery, Kirin Beverage, Kyowa Kirin, and Blackmores. Kirin Holdings operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Nakano, Japan
-
Sectors
Financial ServicesHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Yangtze River Development Ltd
-
Annual Revenue
Not available
-
Net Profit
-$12.73 M (USD)-99as on Dec 31, 2016
-
EBITDA
-$5.45 M (USD)-20as on Dec 31, 2016
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kirin Holdings
Kirin Holdings offers a comprehensive portfolio of products and services, including Kirin Brewery, Kirin Beverage, Kyowa Kirin, and Blackmores.
Produces beer and other alcoholic drinks for consumers
Offers soft drinks and beverages globally
Develops and supplies life-changing drugs
Provides nutritional supplements and health products
People of Kirin Holdings
Unlock access to complete
Leadership Team
20 people
Board Team
4 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Kirin Holdings
Detailed funding history for Kirin Holdings
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kirin Holdings
Kirin Holdings has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Blackmores.
Investment portfolio details for Kirin Holdings
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Health products for humans and animals, including vitamins, herbal and mineral nutritional supplements.
|
Locked | Locked | 1932 | Locked |
Complete acquisition details for Kirin Holdings
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Kirin Holdings
Detailed financials for Kirin Holdings
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kirin Holdings Comparisons
Peer comparison for Kirin Holdings
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kirin Holdings
Kirin Holdings operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
Detailed competitors of Kirin Holdings
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kirin Holdings
Complete news archive for Kirin Holdings
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kirin Holdings
Kirin Holdings was founded in 2010.
Kirin Holdings is headquartered in Nakano, Japan. It is registered at Nakano, Tokyo, Japan.
Yoshinori Isozaki is the current CEO of Kirin Holdings.
Kirin Holdings was founded in 2010 and is headquartered in Nakano, Japan. Operations center on delivering financial services to support investment activities across various sectors. Core offerings include advisory and management solutions for investors, with a focus on regional markets. The company is led by CEO Yoshinori Isozaki, ensuring structured oversight of its financial provisions.
Kirin Holdings's top competitors include Merck, Roivant Sciences and AbbVie.
Kirin Holdings offers Kirin Brewery, Kirin Beverage, Kyowa Kirin, and Blackmores.
Kirin Holdings has made 1 acquisition, including Blackmores.